Quest Diagnostics is working with the Centers for Disease Control and Prevention (CDC) to improve public health analysis of screening, diagnosis and treatment for the hepatitis C virus (HCV), according to a Quest statement. Under the agreement, medical experts will share data from the CDC’s de-identified hep C test result database and from Quest Diagnostics’ Health Trends national clinical laboratory database to identify and track epidemiological hep C trends. The focus is primarily on baby boomers born between 1945 and 1965. Both CDC and Quest researchers will determine how testing and treatment trends differ for hep patients based on gender, age, geography and clinical management. The CDC and Quest will jointly publish their research results.

To read the statement, click here.